Table 2.
Gene | Sham | CCI 3 days | CCI/JNJ16259685 3 days | CCI 7 days | CCI/JNJ16259685 7 days |
---|---|---|---|---|---|
bax/HPRT | 0.17±0.03 | 0.68±0.13* | 0.67±0.20* | 0.21±0.02 | 0.18±0.02 |
bcl-2/HPRT | 0.43±0.05 | 0.36±0.04 | 1.25±0.18*° | 0.71±0.04* | 1.34±0.27*° |
GFAP/HPRT | 5.21±0.31 | 13.02±0.60* | 19.79±0.35° | 11.04±1.21* | 5.83±0.18° |
APAF-1/HPRT | 0.63±0.11 | 1.62±0.32* | 0.53±0.02° | 0.98±0.13* | 0.69±0.10° |
caspase-7/HPRT | 1.02±0.06 | 1.64±0.08* | 0.84±0.04° | 0.83±0.09 | 1.30±0.06* |
p<0.05 vs the corresponding sham,
p<0.05 vs the CCI JNJ16259685 untreated rats, as analysed by ANOVA, followed by Student-Neuman-Keuls test. JNJ16259685 did not affect behavioural analysis in sham rats. For this reason we did not perform other experiments on JNJ16259685 treatment in sham rats.